Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | PINOS, YAZMIN |
| Género | Mujer |
| Área Principal WOS | Immunology; Biology; Infectious Diseases; |
| Afiliación Principal | Hosp Base San Jose |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| WOS | #Pub |
|---|---|
| Immunology | 2 |
| Biology | 1 |
| Infectious Diseases | 1 |
| Medicine, General & Internal | 1 |
| Cell Biology | 1 |
| Scopus | #Pub |
|---|---|
| Public Health, Environmental And Occupational Health | 1 |
| Infectious Diseases | 1 |
| Medicine (All) | 1 |
| Pharmacology (Medical) | 1 |
| Dermatology | 1 |
| SciELO | #Pub |
|---|
| Título | Año | Citas | Tipo | Revista | Indexada |
|---|---|---|---|---|---|
| Is It Worth Adding Loperamide To The Antibiotic Treatment Of Travelers Diarrhea? | 2017 | 1 | artículo de investigación | Medwave | WoS Scopus |
| Clinical Characteristics And Outcomes Of People Living With Hiv Hospitalized With Covid 19: A Nationwide Experience | 2021 | 28 | artículo de investigación | International Journal Of Std & Aids | WoS Scopus |
| Sustained Antibody Dependent Nk Cell Functions In Mild Covid 19 Outpatients During Convalescence | 2022 | 7 | artículo de investigación | Frontiers In Immunology | WoS Scopus |
| Ig G Targeting Distinct Seasonal Coronavirus Conserved Sars Co V 2 Spike Subdomains Correlates With Differential Covid 19 Disease Outcomes | 2022 | 9 | artículo de investigación | Cell Reports | WoS Scopus |
| Longitudinal Transcriptional Changes Reveal Genes From The Natural Killer Cell Mediated Cytotoxicity Pathway As Critical Players Underlying Covid 19 Progression | 2024 | 0 | artículo de investigación | E Life | WoS Scopus |
| Palabra Clave | #Pub |
|---|---|
| covid-19 | 4 |
| sars-cov-2 | 4 |
| infection | 2 |
| receptor | 1 |
| neutralizing antibodies | 1 |
| nk | 1 |
| nk cells activity | 1 |
| oc43 | 1 |
| outcomes | 1 |
| outpatients | 1 |
| pandemic | 1 |
| pbmc rna-seq | 1 |
| placebo | 1 |
| plus loperamide | 1 |
| protection | 1 |
| randomized-trial | 1 |
| innate | 1 |
| region | 1 |
| reinfection | 1 |
| responses | 1 |
| sars1 | 1 |
| self-treatment | 1 |
| severity | 1 |
| spike (s) glycoprotein | 1 |
| sulfamethoxazole | 1 |
| titers | 1 |
| trimethoprim | 1 |
| us military personnel | 1 |
| fc-gamma receptor activation | 1 |
| antibody-mediated effector responses | 1 |
| azithromycin | 1 |
| binding | 1 |
| cells | 1 |
| ciprofloxacin | 1 |
| coronavirus | 1 |
| cp: immunology | 1 |
| cp: microbiology | 1 |
| disease | 1 |
| disease severity | 1 |
| fc effector functions | 1 |
| fc-effector functions | 1 |
| microbiology | 1 |
| fusion protein region | 1 |
| gamma | 1 |
| heptad repeat region | 1 |
| hiv | 1 |
| hr2 | 1 |
| human | 1 |
| human betacoronavirus | 1 |
| immunity | 1 |
| immunoglobulin-like receptors | 1 |
| infectious disease | 1 |
| ade | 1 |